I One may sell IndusInd Bank for a target price of Rs 500 and keep a stoploss at Rs 547. One may sell Aurobindo Pharma for a target price of Rs... ...http://www.moneycontrol.com/news/stocks-views/sell-indusind-bank-bharat-forge-arvind-paras-bothra_1125182.html
B On Bull's Eye this week - Manav Chopra, Kunal Saraogi and Paras Bothra are battling it out for the strongest portfolio. Let's hear out their... ...http://www.moneycontrol.com/news/stocks-views/bulls-eye-buy-bata-dhfl-short-titan-aurobindo-pharma_1125014.html
By Kanchana Dwarakanath All inclusive development in Pharma Biotech will lead to expansion, thus creation of jobs If there is one thing that the... ...http://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/budget-2014-modi-govt-should-increase-healthcare-spends-to-5-of-gdp/articleshow/37962481.cms
Sharekhan has come out with its report on Lupin . A vast geographical presence, focus on niche segments like oral contraceptives, ophthalmic... ...http://www.moneycontrol.com/news/brokerage-recos-fundamental/expect-lupins-profit-cagr17-over-fy2014-16-sharekhan_1118246.html
The government has approved four (4) proposal involving Foreign Direct Investment. Further to Para 6 of the Press Release dated May 20,... ...http://www.indiainfoline.com/Markets/News/FDI/5957819714
Ultimate Job Portal for Healthcare...